News & Events
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
Crinetics announces positive initial findings from its ongoing open-label Phase 2 carcinoid syndrome study of paltusotine, an oral, once-daily investigational compound being developed for the treatment of acromegaly and carcinoid syndrome.
READ MORECrinetics Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 94,000 shares of its common stock to six new non-executive employees
READ MORECrinetics Pharmaceuticals to Participate in Upcoming Investor Conferences
Crinetics management will participate in fireside chats at the 6th Annual Evercore ISI HealthCONx Conference on November 28 and the Piper Sandler 35th Annual Healthcare Conference on November 30.
READ MORECrinetics Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 83,600 shares of its common stock to four new non-executive employees
READ MORECrinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Crinetics Pharmaceuticals reported financial results and provided an update on third quarter 2023 progress
READ MORECrinetics Announces October 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 619,100 shares of its common stock to eleven new non-executive employees
READ MORECrinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
Crinetics management will participate in a fireside chat and conduct investor meetings at the Cantor Global Healthcare Conference on September 26, 2023
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
